Company / Gross Margin
IMMUCELL CORP /DE/ Gross Margin History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
30.0%
FY2025
5-year range
22.1% / 61.1%
FY2021-FY2025
Trend
+35.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin returned to growth in FY2025 after 3 years of decline, reaching 30.0%.
Based on SEC 10-K filings.
30.0% in FY2025 with a 10-year CAGR of -21.0%.
Declined from 41.2% to 30.0% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -21.0pp
Key checks
Key Insights
- In FY2025, gross margin increased 35.3% year-over-year.
- Peak gross margin was recorded in FY2016.
- Lowest gross margin in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 30.0% | +35.3% |
| FY2024 | 22.1% | -46.2% |
| FY2023 | 41.2% | -27.5% |
| FY2017 | 56.8% | -7.1% |
| FY2016 | 61.1% | +19.9% |
| FY2015 | 50.9% | -10.1% |
| FY2014 | 56.7% | +2.9% |
| FY2013 | 55.0% | +4.9% |
| FY2012 | 52.5% | -1.4% |
| FY2011 | 53.2% | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026